FDA Looking For New Biologics Center Director With Midthun Set To Retire

FDA is searching for a new director for the Center for Biologics Evaluation and Research, as current Director Karen Midthun is set to retire at the end of the year after working at the agency for 22 years, according to an FDA spokesperson. As director, Midthun oversaw the review of biological products, including vaccines, allergenic products, blood and blood products and cellular, tissue and gene therapies. Prior to joining the agency, she was involved in the clinical development of investigational...